Ironwood Financial’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-297
Closed -$18K 317
2021
Q3
$18K Hold
297
0.01% 292
2021
Q2
$18K Hold
297
0.01% 291
2021
Q1
$18K Hold
297
0.01% 276
2020
Q4
$18K Buy
297
+261
+725% +$14.9K 0.01% 265
2020
Q3
$2K Buy
+36
New +$1.94K ﹤0.01% 388

Other funds holding IHE

Ironwood Financial's IHE Position: Q4 2021 in Review

Ironwood Financial sold out of iShares US Pharmaceuticals ETF (IHE) in Q4 2021, closing a stake of 297 shares — an estimated $18K sold.

Ironwood Financial first reported a position in IHE in Q3 2020 and held it in 5 quarters. The position peaked at $18K in Q3 2021. 112 funds tracked by Wall St. Rank hold IHE as of Q4 2021.

  • Ironwood Financial reported no remaining iShares US Pharmaceuticals ETF position as of Q4 2021 after selling out during the quarter.
  • Ironwood Financial sold 297 iShares US Pharmaceuticals ETF shares in Q4 2021, an estimated $18K.
  • Ironwood Financial first reported a position in iShares US Pharmaceuticals ETF in Q3 2020 and held it in 5 quarters.
  • Ironwood Financial's iShares US Pharmaceuticals ETF position peaked at $18K in Q3 2021.
  • 112 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q4 2021.

Based on Ironwood Financial's 13F filing for Q4 2021, filed 28 Jan 2022.